Accelerated biomarker discovery with advanced metabolomics investigation

Standardization, reproducibility, and access to validated platforms remain the biggest challenges in metabolomics research. In this video, discover how biocrates, a world leader in quantitative, mass-spectrometry-based metabolomics, is addressing these challenges head-on. Founded in 2002 and headquartered in Innsbruck, Austria, biocrates empowers researchers with standardized kits, software, and contract research services, enabling the quantification of up to 1,800 biomarkers from less than one drop of blood. At this year’s ASMS, biocrates unveils its next-generation kit: the MxP^® Quant 1000.

Learn how this cutting-edge solution is helping scientists bring their research closer to clinical application. Hear from Chris Basting, a PhD student at the University of Minnesota, as he shares how the MxP^® Quant 1000 advanced his study on chronic inflammation in people living with HIV, even leading to an unexpected discovery.